Advertisement

Waltham-based PerkinElmer Inc. has acquired chemagen Biopolymer-Technologie AG, Germany-based maker of automated nucleic acid isolation with operations in Worcester, for an undisclosed amount.

According to Daniel R. Marshak, chief scientific officer and president of the emerging diagnostics unit at PerkinElmer (NYSE: PKI), the purchase is part of the company’s strategy to move deeper into the molecular diagnostics and research markets. By being able to offer the nucleic acid products, PerkinElmer will be able to better serve both businesses and researchers looking into genomics analysis, DNA identification and other areas related to DNA and RNA.

SOURCE

Advertisement
Advertisement